NCT06807580View on ClinicalTrials.gov

Progesterone in Gender Affirming Hormone Therapy Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Transgender Women
Interventions
DRUG

Placebo

The placebo will be nearly identical in size, color, and shape to micronized progesterone

DRUG

Progesterone

Oral micronized progesterone 200 mg

Trial Locations (1)

30308

RECRUITING

Emory Transgender Clinic, Atlanta

All Listed Sponsors
lead

Emory University

OTHER